ReNeuron is a leading, clinical-stage stem cell business. Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need. www.reneuron.com
Many thanks to all those who attended the first ever UK Stroke Assembly. You helped make it such a success. There was a wonderful buzz throughout the two days. People affected by stroke discussed a variety of issues, such as welfare reform, local campaigning, volunteering and stroke research. Delegates also discovered products and services designed for stroke survivors in the exhibition area, and relaxed with reflexology, massage and art therapy.
Of major concern to delegates were the planned changes to the benefits system.